Evidence-based therapy for type 2 diabetes. The best and worst of times. - Wikidata - awgldk - TriplyDB

Evidence-based therapy for type 2 diabetes. The best and worst of times.

Evidence-based therapy for type 2 diabetes. The best and worst of times.

http://www.wikidata.org/entity/Q33938385

about

Evidence-based therapy for type 2 diabetes. The best and worst of times.

http://www.wikidata.org/entity/Q33938385

description

2000 nî lūn-bûn

@nan

2000 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@ast

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@en

type

label

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@ast

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@en

prefLabel

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@ast

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@en

P1433

Q33938385-162D5516-F21D-468B-8E3D-DE15885DE221

P1476

Q33938385-AF4C25C7-14E6-4AA2-8060-9FD27CF10161

P2093

Q33938385-93DA1A8B-3B11-4691-81D2-53DE15630CAA

Q33938385-F7495BB0-E18B-454F-A05D-F86D5B96521C

P2860

Q33938385-18DE8716-8BD7-4B6F-97E1-7295AA006688

Q33938385-1967083D-5D6C-415E-8E3A-B3E5F142B772

Q33938385-47EBA96C-4AEB-46CF-B622-A87EC7FF83C6

Q33938385-66CF39AF-4CE5-4402-8DAF-5C88579BE94A

Q33938385-726DBE6E-5551-4416-B9A5-3C9AA1BCF9F7

Q33938385-783F73F7-6740-4619-A0E4-3AAEDDD61592

Q33938385-8DE8E0BE-6403-4295-A538-FDB13525B5E5

Q33938385-95FFE4FD-DE8A-42E7-B01A-F036A31768D5

Q33938385-B0F0E522-8FFC-4CB6-A70D-7112F4EEBBDC

Q33938385-BCDC7A71-C922-4471-B2FF-CF1331AC76C4

P304

Q33938385-508431DA-3B11-4FC8-9A37-9E03F1BBB594

P31

Q33938385-1E093E51-F0DE-4D2C-91E8-28FF7C705C58

P356

Q33938385-EA5963C2-C942-4BCB-ADD1-0DD263B1E9A3

P407

Q33938385-4A35777B-7B1C-48C3-9680-FECB28AE001E

P433

Q33938385-200785DF-F6E4-4199-81CE-43D65A0A5D60

P478

Q33938385-E04DD4A1-C9F6-41B3-941B-69981C541FE3

P577

Q33938385-30510E74-AE2B-4B5D-AC91-49682CE01FFF

P698

Q33938385-5B9FCDD9-EF6C-4DAA-B8D3-C851FB3FB612

P921

Q33938385-0DD84D66-6C56-47B7-B7D9-C8CBC97F886D

P356

PGM.2000.5.1.1064

P1433

Postgraduate Medicine

P1476

Evidence-based therapy for type 2 diabetes. The best and worst of times.

@en

P2093

A I Vinik

http://www.w3.org/2001/XMLSchema#string

M C Flemmer

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

P304

27-8, 31-4, 37-40, passim

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2000.5.1.1064

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10844940

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes